Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$305M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
ExxonMobil
XOM
|
+$277M |
| 4 |
Warner Bros
WBD
|
+$263M |
| 5 |
Linde
LIN
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
CERN
Cerner Corp
CERN
|
+$371M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$310M |
| 4 |
Philip Morris
PM
|
+$254M |
| 5 |
S&P Global
SPGI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 11.99% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
3976
Niagen Bioscience
NAGE
$241M
| $145K | ﹤0.01% |
86,998
-118,408
| -58% | -$232K |
|
|
BXMX
3977
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $144K | ﹤0.01% |
+11,621
| New | +$156K |
|
3978
Eos Energy Enterprises
EOSE
$1.51B
| $143K | ﹤0.01% |
118,425
-6,020
| -5% | -$12.3K |
|
|
BGRY
3979
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $143K | ﹤0.01% |
98,961
+83,135
| +525% | +$184K |
|
3980
Itaú Unibanco
ITUB
$80.9B
| $142K | ﹤0.01% |
37,788
-1,839
| -5% | -$8.17K |
|
3981
Urban One Class D
UONEK
$24.1M
| $142K | ﹤0.01% |
+3,309
| New | +$193K |
|
|
ADTH
3982
DELISTED
AdTheorent Holding Co
ADTH
| $142K | ﹤0.01% |
45,783
+26,729
| +140% | +$201K |
|
3983
Innodata
INOD
$2.03B
| $141K | ﹤0.01% |
29,137
-1,979
| -6% | -$12.8K |
|
3984
PDS Biotechnology
PDSB
$13M
| $139K | ﹤0.01% |
38,150
-607
| -2% | -$2.89K |
|
3985
Comscore
SCOR
$91.6M
| $139K | ﹤0.01% |
3,371
-10,260
| -75% | -$427K |
|
3986
Acacia Research
ACTG
$449M
| $138K | ﹤0.01% |
27,411
-166,327
| -86% | -$763K |
|
|
USX
3987
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $138K | ﹤0.01% |
51,617
-48,782
| -49% | -$152K |
|
3988
X4 Pharmaceuticals
XFOR
$425M
| $135K | ﹤0.01% |
4,657
-30
| -0.6% | -$1.14K |
|
3989
AST SpaceMobile
ASTS
$21.4B
| $134K | ﹤0.01% |
21,414
| – | – |
|
|
HIMX
3990
Himax Technologies
HIMX
$2.56B
| $134K | ﹤0.01% |
17,936
+1,181
| +7% | +$10.9K |
|
|
TCON
3991
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $134K | ﹤0.01% |
3,352
-3,761
| -53% | -$146K |
|
|
SA
3992
Seabridge Gold
SA
$3.46B
| $133K | ﹤0.01% |
10,704
+306
| +3% | +$4.9K |
|
3993
CEL-SCI Corp
CVM
$26M
| $132K | ﹤0.01% |
982
-3,315
| -77% | -$345K |
|
3994
Orion Energy Systems
OESX
$78.9M
| $132K | ﹤0.01% |
6,582
+2,854
| +77% | +$70.2K |
|
3995
Matinas BioPharma
MTNB
$1.49M
| $131K | ﹤0.01% |
3,325
-64
| -2% | -$2.44K |
|
3996
Savara
SVRA
$1.08B
| $131K | ﹤0.01% |
+86,178
| New | +$113K |
|
3997
Alaunos Therapeutics
TCRT
$4.86M
| $130K | ﹤0.01% |
697
-3,884
| -85% | -$371K |
|
|
SDC
3998
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $130K | ﹤0.01% |
124,896
-1,646
| -1% | -$2.66K |
|
|
RDBX
3999
DELISTED
Redbox Entertainment Inc. Class A Common Stock
RDBX
| $130K | ﹤0.01% |
+17,550
| New | +$104K |
|
4000
Rapid Micro Biosystems
RPID
$85.3M
| $129K | ﹤0.01% |
30,000
-33,178
| -53% | -$154K |
|
Similar funds
Bank of New York Mellon's Q2 2022 Portfolio in Review
As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
- Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
- Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
- Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
- Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
- Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.